PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 17th, 2014 • Globeimmune Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 17th, 2014 Company Industry JurisdictionThis Placement Agency Agreement (“Agreement”) sets forth the terms upon which Aegis Capital Corp., a New York corporation, and a registered broker-dealer and member of the Financial Industry Regulatory Authority (“FINRA”) (the “Placement Agent”), shall be engaged by GlobeImmune, Inc., a Delaware corporation (the “Company”), to act as its exclusive Placement Agent in connection with the private placement (the “Offering”) of units (“Units”) of securities of the Company, each Unit consisting of (i) a 10% Convertible Term Note in a principal amount of $250,000 (each, a “Note” and collectively, the “Notes”), convertible into securities of the Company determined as set forth in the Notes, and (ii) a warrant (each, a “Warrant” and collectively, the “Warrants”), with each Warrant entitling the holder to purchase $250,000 of securities of the Company determined as set forth in the Warrants. The Offering will consist of a maximum of 20 Units ($5,000,000) (the “Maximum Amount”). If the Offering i
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 31st, 2010 • Manhattan Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 31st, 2010 Company Industry JurisdictionManhattan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (the “Agreement”) with National Securities Corporation, a Washington corporation (the “Placement Agent”) as follows: